NeuroSense Therapeutics Ltd (NASDAQ:NRSN) currently has a daily average trading volume of 292.47K but it saw 96203 shares traded in last market. With a market cap of 25.85M USD, the company’s current market price of $1.12 came falling about -5.84 while comparing to the previous closing price of $1.19. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.33 and as low as $0.51. In the recent trading on the day, stock has struck highest price mark of $1.1 while lowest mark touched by it was $1.165.
Taking a look at 20-day trading activity of NeuroSense Therapeutics Ltd (NRSN) gives us an average price of $1.1424, while its current price level is -52.02% below from 52-week high level whereas it is 118.34% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.1484 while that of 200 days or SMA-200 reads an average of $1.1380. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.13% during that period while stretching the period over a month that increases to 13.23%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 47.24 which implies that the stock is in neutral territory.
Over the week, NRSN’s stock price is moving -6.84% down while it is 7.49% when we observe its performance for the past one month. Year-to-date it is -6.84% down and over the past year, the stock is showing an upside performance of 41.54%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, NeuroSense Therapeutics Ltd’s total number of outstanding shares is 19.81M. Company’s return on equity (ROE) at -602.40%. Stock’s beta reads 1.29. Its return on asset (ROA) is -356.64% on average.
